Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
Volume 0.30M
Average 0.34M
COAG Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Gross Margin history
Percent of revenue · from the income statement
No Gross Margin data reported for this period type.
Gross Margin vs competitors
How COAG compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 99.7% | +7.2 pp | — | |
| LTM Mar 2026 | 74.1% | +20.2 pp | -7.3 pp | |
COAGHemab Therapeutics Holdings, Inc. Common Stock | FY2025 | — | — | — |
IRONDisc Medicine, Inc. | FY2025 | — | — | — |
DMRADamora Therapeutics, Inc. | FY2025 | — | — | — |
| Peer median (excluding COAG) | 86.9% | +13.7 pp | -7.3 pp | |
Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 0 |
| Cost of Revenue | 0 |
| Gross Profit | 0 |
| Gross Margin | — |
| Research & Development | 59.63M |
| Selling, General & Admin | 10.49M |
| Operating Expenses | 70.12M |
| Depreciation & Amortization | 304K |
| EBITDA | (69.82M) |
| EBITDA Margin | — |
| Operating Income | (70.12M) |
| Operating Margin | — |
| Interest Income | 1.97M |
| Interest Expense | 0 |
| Other Income / Expenses | 5.98M |
| Income Before Tax | (64.14M) |
| Pre-Tax Margin | — |
| Income Tax Expense | (227K) |
| Net Income | (63.91M) |
| Net Margin | — |
| EPS (Basic) | (2.33) |
| EPS (Diluted) | (2.33) |
| Weighted Avg Shares | 27.44M |
| Weighted Avg Shares (Diluted) | 27.44M |
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
Intrinsic Alpha fair value
Locked
Current Price
$39.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.